Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography

Rheumatology (United Kingdom)

Volumn 54, Issue 4, 2014, Pages 647-654

  Rodríguez Reyna, Tatiana S ^a   Morelos Guzman, Martha ^a   Hernández Reyes, Pablo ^a   Montero Duarte, Karla ^a   Martínez Reyes, Cynthia ^a   Reyes Utrera, Carlos ^a   Madrid, Jorge Vazquez La ^a   Morales Blanhir, Jaime ^a   Núñez Álvarez, Carlos ^a   Cabiedes Contreras, Javier ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Atherosclerosis; Coronary angiotomography; Coronary artery disease; Magnetic resonance image; Microvascular damage; Myocardial fibrosis; Scleroderma

Indexed keywords

C REACTIVE PROTEIN; IOPAMIDOL; PENTETIC ACID;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; CORONARY ANGIOTOMOGRAPHY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART MUSCLE PERFUSION; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NORMAL VALUE; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS; TOMOGRAPHY;

EID: 84926479423     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu350     Document Type: Article

References (29)

1. Masi AT, Rodnan GP, Medsger TA Jr et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
2. Medsger TA Jr, Bombardieri S, Czirjak L et al. The assessment of the patient with systemic sclerosis. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003;21(Suppl 29):S42-6.
3. Medsger TA Jr. Classification, prognosis. In: Clemens PJ, Furst DE, eds. Systemic Sclerosis. Philadelphia, PA, USA: Lippincott Williams & Wilkins, 2004:17-28.
4. Follansbee WP, Marroquin OC. Cardiac involvement in systemic sclerosis. In: Clemens PJ, Furst DE, eds. Systemic Sclerosis. Philadelphia, PA, USA: Lippincott Williams & Wilkins, 2004:195-220.
5. Meune C, Allanore Y, Devaux J et al. High prevalence of right ventricular systolic dysfunction in early systemic sclerosis. J Rheumatol 2004;31:1941-5.
6. Follansbee WP, Curtiss EI, Medsger TA Jr et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984;310:142-8.
7. Mavrogeni S, Sifikakis PP, Gialafos E et al. Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res 2014;66:104-12.
8. Follansbee WP, Miller TR, Curtis EI et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990;17:656-2.
9. Steen VD, Follansbee WP, Conte CG, Medsger TA Jr. Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis. Arthritis Rheum 1996;39:677-81.
10. Follansbee WP, Curtiss EI, Medsger TA Jr et al. Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Am J Med 1984; 77:489-96.
11. Follansbee WP, Curtiss EI, Rahko PS et al. The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature. Am J Med 1985;79:183-92.
12. Vacca A, Montisci R, Cauli A et al. A. Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography: a myocardial echostress scleroderma pattern. Ann Rheum Dis 2006;65:1669-70.
13. Ferri C, Di Bello V, Martini A et al. Heart involvement in systemic sclerosis: an ultrasonic tissue characterisation study. Ann Rheum Dis 1998;57:296-302.
14. Rokas S, Mavrikakis M, Agrios N et al. Electrophysiologic abnormalities of cardiac function in progressive systemic sclerosis. J Electrocardiogr 1996;29:17-25.
15. Ridolfi RL, Bulkley BH, Hutchins GM. The cardiac conduction system in progressive systemic sclerosis: clinical and pathologic features of 35 patients. Am J Med 1976;61: 361-6.
16. Kim RJ, Fieno DS, Parrish TB et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100: 1992-2002.
17. Oflaz S, Yucel B, Oz F et al. Assessment of myocardial damage by cardiac MRI in patients with anorexia nervosa. Int J Eat Disord 2013;46:862-6.
18. Karlstedt E, Chevlanathat A, Da Silva M et al. The impact of repeated marathon running on cardiovascular function in the aging population. J Cardiovasc Magn Reson 2012; 14:58.
19. Wilson M, O'Hanlon R, Prasad S et al. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol 2011;110:1622-6.
20. Hachulla AL, Launay D, Gaxotte V et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 2009;68:1878-84.
21. Tzelepis GE, Kelekis NL, Plastiras SC et al. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 2007;56:3827-36.
22. Mavrogeni S, Bratis C, Manoussais M. Coronary artery abnormalities in CREST syndrome revealed by cardiovascular magnetic resonance imaging. Can J Cardiol 2011;27390.e5-7.
23. Kobayashi H, Yokoe I, Hirano M et al. Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis. J Rheumatol 2009;36: 106-12.
24. Nassenstein K, Breuckmann F, Huger M et al. Detection of myocardial fibrosis in systemic sclerosis by contrastenhanced magnetic resonance imaging. Rofo 2008;180: 1054-60.
25. Vogel-Claussen J, Skork J, Shehata ML et al. Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension. Radiology 2011;258:119-27.
26. O'Neill JO, McCarthy PM, Brunken RC et al. PET abnormalities in patients with nonischemic cardiomyopathy. J Card Fail 2004;10:244-9.
27. Clements PJ, Furst DE, Cabeen W et al. The relationship of arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS). Am J Med 1981;71: 38-46.
28. Roberts NK, Cabeen WR. Atrioventricular nodal function in progressive systemic sclerosis: electrophysiological and morphological findings. Br Heart J 1980;44: 529-33.
29. Vacca A, Meune C, Gordon J et al. Cardiac arrhythmias and conduction defects in systemic sclerosis. Rheumatology 2014;53:1172-7.